Watch Omniscope in action.
The objective of Omniscope for the EPIVINF project is to test the hypothesis that epigenetic control mechanisms, especially DNA methylation processes that govern the expression of host proteins involved in antiviral immunity to HIV and SARS-CoV-2, play a decisive role in the outcome of vaccination for these pathogens.
At the World Vaccine Congress in Barcelona, Prof. Dr. Holger Heyn and Vijay Vaswani from Omniscope shared insights into how AI and immune profiling accelerate vaccine innovation. Their work emphasizes the importance of understanding immune system responses at a cellular level to develop next-generation vaccines and diagnostics.
The objective of Omniscope for the EPIVINF project is to test the hypothesis that epigenetic control mechanisms, especially DNA methylation processes that govern the expression of host proteins involved in antiviral immunity to HIV and SARS-CoV-2, play a decisive role in the outcome of vaccination for these pathogens.
Dr. Sharland explains the aim of Tackle-it consortium and the role of Omniscope, profiling TCR repertoires of blood samples of 40 kidney-transplanted patients collected at baseline and at 3 months post-intervention to correlate changes.
Round table discussion delving into harnessing the immune system's power to advance precision oncology efforts. Panel: Dr. Frankis Almaguel, Dr. Holger Heyn, Dr. Jose M. Piulats, Dr. Aleix Prat, and moderator Vijay Vaswani.
Omniscope is a partner of Google Cloud and to celebrate our collaboration, Omniscope was featured during the main keynote 'AI for good' at Google Cloud Day Barcelona 2024.
Omniscope is a partner of Google Cloud and to celebrate our collaboration, Omniscope was featured during the main keynote 'AI for good' at Google Cloud Summit Madrid 2024.
Omniscope is a partner of Google Cloud and to celebrate our collaboration, Omniscope was featured during the main keynote 'AI for good' at Google Cloud Summit Madrid 2024.
